| Article ID | Journal | Published Year | Pages | File Type | 
|---|---|---|---|---|
| 3360485 | International Journal of Antimicrobial Agents | 2009 | 4 Pages | 
Abstract
												New, aggressive forms of immunosuppression and an increasing population of patients at risk provide fertile ground for opportunistic invasive fungal infections (IFIs). Particularly challenging is the changing epidemiology of IFIs: rare pathogens are now more common and resistant strains are emerging among species that are generally considered to be sensitive. Staying one step ahead of this evolving epidemiology is a major task and some 400 delegates, from 44 countries, learned that although there has been considerable progress, more is needed.
Keywords
												
											Related Topics
												
													Life Sciences
													Immunology and Microbiology
													Applied Microbiology and Biotechnology
												
											Authors
												Andreas H. Groll, Liz McNeil Grist, 
											